Chemical Compound

(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-Azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- (9CI); (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; BMS 477118; BMS 477118-11; Onglyza; Saxagliptin

CAS Registry Number 361442-04-8
返回搜索 申请报价
(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-Azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- (9CI); (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; BMS 477118; BMS 477118-11; Onglyza; Saxagliptin 结构式
Primary record

(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-Azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- (9CI); (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; BMS 477118; BMS 477118-11; Onglyza; Saxagliptin

库存
6,995 克
纯度
98.2 %
CAS
361442-04-8

化合物标识与属性

CAS
361442-04-8
PubChem CID
11243969
SMILES
C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N
Canonical SMILES
N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2

名称与同义词

  • Saxagliptin
  • Onglyza
  • 361442-04-8
  • Saxagliptine
  • saxagliptinum
  • Saxagliptin anhydrous
  • Saxagliptina
  • Saxagliptin [INN]
  • Saxagliptin?
  • Saxagliptin HCl
  • Saxagliptin hydrate
  • BMS-477118
  • Onglyza (TN)
  • Saxagliptin [USAN]
  • saxagliptin monohydrate
  • Kombiglyze XR (TN)
  • 8I7IO46IVQ
  • Saxagliptin hydrochloride
  • UNII-8I7IO46IVQ
  • SAXAGLIPTIN [MI]
  • OPC-262
  • RefChem:931331
  • BMS 477118
  • Saxagliptin (USAN/INN)
  • DTXSID7048580
  • D0K9MY
  • UNII-9GB927LAJW
  • CHEMBL385517
  • 9GB927LAJW
  • SCHEMBL17168
  • DTXCID3028506
  • SAXAGLIPTIN [WHO-DD]
  • cc-226
  • CHEBI:71272
  • HSDB 8199
  • MLS006011223
  • OPC 262
  • BMS477118
  • MFCD12756398
  • Saxagliptin [USAN:INN:BAN]
  • GTPL6316
  • Saxagliptin - BMS-477118
  • BDBM11542
  • A10BH03
  • NSC760407
  • QGJUIPDUBHWZPV-SGTAVMJGSA-N
  • C18H25N3O2
  • HMS3264P11
  • Pharmakon1600-01502500
  • NSC-760407
  • BMS-477118-11
  • MSK10924
  • SBMS-477118
  • Tox21_112908
  • BDBM50225074
  • EBC-02059
  • QTERNMET COMPONENT SAXAGLIPTIN
  • s1540
  • Saxagliptin (BMS-477118,Onglyza)
  • AKOS015896547
  • Saxagliptin for system suitability CRS
  • AC-6008
  • ACN-031557
  • AN-5808
  • CCG-213084
  • CCG-267647
  • CS-0650
  • DB06335
  • EX-7795
  • FA29598
  • CID11243969
  • NCGC00242597-01
  • NCGC00242597-02
  • NCGC00242597-10
  • CID:11243969
  • HY-10285
  • SMR004702984
  • SY022234
  • BMS 477118-11
  • SID:121147387
  • AB1008460
  • AM20090693
  • CAS-361442-04-8
  • FT-0660429
  • D08996
  • EN300-761487
  • Q-4418
  • AB01562984_01
  • AB01562984_02
  • A852139
  • C502994
  • 3-hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate
  • I06-2477
  • Q3121121
  • BRD-A81513827-001-03-6
  • (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile
  • (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • Z2235802036
  • (1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • (S)-3-hydroxyadamantylglycine-L-cis-4,5-methanoprolinenitrile
  • (1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl) acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile hydrate
  • (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • (1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • (S)-3-Hydroxyadamantylglycine-L-cis-4,5-methanoprolinenitrile TFA salt
  • 1073057-20-1
  • 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)-
  • 945667-22-1
  • Saxagliptin, 97%, selective and reversible DPP4 inhibitor - 10MG 10mg
  • (1S,6S)-2-(2-adamantan-1-yl-2-amino-acetyl)-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile
  • 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3
  • (1S,3S,5S)-2-((2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile
  • (1S,3S,5S)-2-((2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile
  • (1S,3S,5S)-2-((2S)-AMINO(3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)ACETYL)-2-AZABICYCLO(3.1.0)HEXANE-3-CARBONITRILE
  • (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2,2,2-trifluoroacetic acid
  • (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1-oxoethyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-Azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- (9CI); (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; BMS 477118; BMS 477118-11; Onglyza; Saxagliptin
  • (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; Onglyza
  • (1S,3S,5S)-2-[(2S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • (1S,3S,5S)-2-[(S)-2-amino-2-(3-hydroxy-adamantan-1-yl)-acetyl]-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile
  • (1s,3s,5s)-2-[2(s)-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • (1S,3S,5S)-2-[2-Amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  • (1S,3S,5S)-4-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-4-azabicyclo[3.1.0]hexane-3-carbonitrile
  • 2-AZABICYCLO(3.1.0)HEXANE-3-CARBONITRILE, 2-((2S)-AMINO(3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)ACETYL), (1S,3S,5S)-
  • 2-Azabicyclo(3.1.0)hexane-3-carbonitrile, 2-((2S)-amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl) , (1S,3S,5S)-
  • 2-Azabicyclo[3.1.0]hexane-3-carbonitrile,2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-,(1S,3S,5S)-
  • 2-Azabicyclo[3.1.0]hexane-3-carbonitrile,2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)-